Association Between Inpatient Steps Per Day and Patient Functional Status/Disposition
NCT03595605 is an interventional trial sponsored by NYU Langone Health. As of 21 Nov 2026, it is completed. It studies Physical Medicine. The registry lists an enrollment of 51 participants at 1 site in 1 country. The registry lists a start date of 16 May 2018 and a primary completion date of 30 Mar 2019.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT03595605 |
| Status | Completed |
| Study type | Interventional trial |
| Lead sponsor | NYU Langone Health |
| Enrollment | 51 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | Physical Medicine |
| Start | 16 May 2018 |
| Primary completion | 30 Mar 2019 |
| Study completion | 30 Mar 2019 |
| Last update posted | 29 May 2020 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Gavriil Ilizarov
NYU Langone Health
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- New York University School of Medicine
New York
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT03595605
Each answer restates registry values shown on this page.
What is NCT03595605?
NCT03595605 is an interventional trial sponsored by NYU Langone Health. It studies Physical Medicine.
Who leads NCT03595605?
The registry names Gavriil Ilizarov (principal investigator, NYU Langone Health) as the overall official.
Where does NCT03595605 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.
When did NCT03595605 end?
The registry lists a primary completion date of 30 Mar 2019 and a study completion date of 30 Mar 2019. The sponsor last updated the record on 29 May 2020.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.